Literature DB >> 27076939

Proteomic profiling differences in serum from silicosis and chronic bronchitis patients: a comparative analysis.

Rongming Miao1, Bangmei Ding1, Yingyi Zhang1, Qian Xia1, Yong Li1, Baoli Zhu1.   

Abstract

BACKGROUND: Silicosis is a severe occupational disease characterized by pulmonary fibrosis, whereas chronic bronchitis (CB) is an acute inflammation of the airways. Differences in the mechanisms of pathogenesis of these diseases are not well understood, therefore we performed proteomic profiling of silicosis and CB patients and, compared the results.
METHODS: Two-dimensional gel electrophoresis and MALDI-TOF-MS (matrix assisted laser desorption ionization time of flight mass spectrometry) were used to identify differentially accumulated proteins in stage I of silicosis (SI), stage II of silicosis (SII) and CB. Enzyme linked immunosorbent assay (ELISA) was employed to validate protein expression data.
RESULTS: A total of 28 and 10 proteins were up- and down-regulated in SI, and 21 and 9 proteins were up- and down-regulated SII, compared with CB. Transforming growth factor beta-1 precursor and interferon beta precursor were up-regulated in CB, while interleukin 6, tumor necrosis factor (TNF) and a variant TNF receptor 13B were down-regulated in CB. Additionally, glycoprotein- and apolipoprotein-associated proteins including apolipoprotein A-IV and α-1-B-glycoprotein were up-regulated in CB, indicating an involvement in the pathogenesis of CB but not silicosis. By contrast, HLA-DRB1, medullasin and the proto-oncogene c-Fos were up-regulated in CB.
CONCLUSIONS: The immune, metabolism and apolipoprotein-related proteins were identified as playing specific and different roles in silicosis and CB. These proteomic profiling differences would facilitate further studies on the mechanisms underlying silicosis and CB, and may also prove useful to disease diagnosis and treatments.

Entities:  

Keywords:  Chronic bronchitis (CB); inflammation; occupational disease; proteomic profile; silicosis

Year:  2016        PMID: 27076939      PMCID: PMC4805800          DOI: 10.21037/jtd.2016.02.68

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  40 in total

1.  Characterization of high molecular weight glycosylated forms of murine tumor necrosis factor.

Authors:  B Sherry; D M Jue; A Zentella; A Cerami
Journal:  Biochem Biophys Res Commun       Date:  1990-12-31       Impact factor: 3.575

2.  HLA-DRB1 associations with rheumatoid arthritis-related pulmonary fibrosis.

Authors:  H Ennis; A Gupta; J Dawson; M Lunt; W Thomson; A Herrick
Journal:  Scand J Rheumatol       Date:  2013-12-03       Impact factor: 3.641

3.  Requirement of tumour necrosis factor for development of silica-induced pulmonary fibrosis.

Authors:  P F Piguet; M A Collart; G E Grau; A P Sappino; P Vassalli
Journal:  Nature       Date:  1990-03-15       Impact factor: 49.962

4.  Anti-caspase-8 autoantibody response in silicosis patients is associated with HLA-DRB1, DQB1 and DPB1 alleles.

Authors:  Ayako Ueki; Yumika Isozaki; Masayasu Kusaka
Journal:  J Occup Health       Date:  2005-01       Impact factor: 2.708

5.  Cluster analysis and display of genome-wide expression patterns.

Authors:  M B Eisen; P T Spellman; P O Brown; D Botstein
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-08       Impact factor: 11.205

6.  Production of tumor necrosis factor-alpha and interleukin-6 by human alveolar macrophages exposed in vitro to coal mine dust.

Authors:  P Gosset; P Lassalle; D Vanhée; B Wallaert; C Aerts; C Voisin; A B Tonnel
Journal:  Am J Respir Cell Mol Biol       Date:  1991-11       Impact factor: 6.914

Review 7.  Systemic manifestations and comorbidities of COPD.

Authors:  P J Barnes; B R Celli
Journal:  Eur Respir J       Date:  2009-05       Impact factor: 16.671

8.  Induction of c-fos and c-jun proto-oncogenes in target cells of the lung and pleura by carcinogenic fibers.

Authors:  Y M Janssen; N H Heintz; J P Marsh; P J Borm; B T Mossman
Journal:  Am J Respir Cell Mol Biol       Date:  1994-11       Impact factor: 6.914

9.  Evidence for the involvement of type I interferon in pulmonary arterial hypertension.

Authors:  Peter M George; Eduardo Oliver; Peter Dorfmuller; Olivier D Dubois; Daniel M Reed; Nicholas S Kirkby; Nura A Mohamed; Frederic Perros; Fabrice Antigny; Elie Fadel; Benjamin E Schreiber; Alan M Holmes; Mark Southwood; Guy Hagan; Stephen J Wort; Nathan Bartlett; Nicholas W Morrell; John G Coghlan; Marc Humbert; Lan Zhao; Jane A Mitchell
Journal:  Circ Res       Date:  2013-12-13       Impact factor: 17.367

10.  Transforming growth factor-β-independent role of connective tissue growth factor in the development of liver fibrosis.

Authors:  Keiko Sakai; Safdar Jawaid; Takako Sasaki; George Bou-Gharios; Takao Sakai
Journal:  Am J Pathol       Date:  2014-08-07       Impact factor: 4.307

View more
  2 in total

1.  Decreased Soluble Receptor of Advanced Glycation End Product Levels Correlated with Inflammation in Silicosis.

Authors:  Heliang Liu; Jingjing Ma; Tian Jiang; Enhong Li; Xiaokun Zhao; Ying Wang; Jie Cui; Xiaohui Hao; Lingli Guo
Journal:  Mediators Inflamm       Date:  2020-04-14       Impact factor: 4.711

2.  Prolonged Inhalation Exposure to Coal Dust on Irradiated Rats and Consequences.

Authors:  Laura Chulenbayeva; Oralbek Ilderbayev; Dametken Suleymeneva; Aizhan Kaliyeva; Symbat Kabdykanov; Madiyar Nurgaziyev; Ayaulym Nurgozhina; Shynggys Sergazy; Samat Kozhakhmetov; Almagul Kushugulova
Journal:  ScientificWorldJournal       Date:  2022-02-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.